Home

Articles from Aradigm Health

Aradigm Launches First-of-Its-Kind Platform to Provide Sustainable Access to Life-Saving Cell and Gene Therapies
Company Closes $20 Million Series A Led by Frist Cressey Ventures and backed by Morgan Health and Andreessen Horowitz
By Aradigm Health · Via GlobeNewswire · December 9, 2025
Articles from Aradigm Health | MarketMinute